510(k) device
AmpliVue Trichomonas Assay
Quidel Corporation · Trichomonas Vaginalis Nucleic Acid Amplification Test System (OUY, Class II) · First FDA decision Mar 17, 2015, newest Mar 17, 2015HIV, hepatitis and sexually transmitted infections
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "AmpliVue"
MAUDE reports
0
Brand "AmpliVue", since 2015
PubMed studies
16
Mentioning "AmpliVue"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AmpliVue Trichomonas Assay
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K143329 · Decided Mar 17, 2015 · 117 days after receipt
Device type: Trichomonas Vaginalis Nucleic Acid Amplification Test System (OUY) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)Local determinationIn effectL38227First Coast Service Options, Inc.Updated Oct 20, 2023
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)Local determinationIn effectL38229Novitas Solutions, Inc.Updated Oct 20, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "AmpliVue", any status and sponsor, newest update first.
No registered device study names "AmpliVue".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AmpliVue", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OUY
30 reports: 25 malfunction, 5 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "AmpliVue"[tiab]. The summary above synthesizes these.
- Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men.
Gaydos CA, Klausner JD, Pai NP, et al. · Sex Transm Infect · 2017Review
- Comparative performance study of six commercial molecular assays for rapid detection of toxigenic Clostridium difficile.
Paitan Y, Miller-Roll T, Adler A · Clin Microbiol Infect · 2017Comparative Study, Evaluation Study
- A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection.
Neuendorf M, Guadarrama-Gonzalez R, Lamik B, et al. · BMC Microbiol · 2016
- Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.
Deak E, Miller SA, Humphries RM · J Clin Microbiol · 2014Comparative Study, Evaluation Study
- Comparative Evaluation of AmpliVue HSV 1+2 Assay with ELVIS Culture for Detecting Herpes Simplex Virus 1 (HSV-1) and HSV-2 in Clinical Specimens.
Granato PA, Alkins BR, Yen-Lieberman B, et al. · J Clin Microbiol · 2015Comparative Study, Multicenter Study
- A large scale clinical evaluation of the AmpliVue and Illumigene molecular tests for the identification of Clostridium difficile-associated diarrhea in adult and pediatric patients.
Antonara S, Daly J, Greene W, et al. · Diagn Microbiol Infect Dis · 2015Comparative Study, Evaluation Study
- Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.
Gaydos CA, Hobbs M, Marrazzo J, et al. · Sex Transm Dis · 2016Evaluation Study
- Clinical evaluation of a helicase-dependant amplification (HDA)-based commercial assay for the simultaneous detection of HSV-1 and HSV-2.
Teo JW, Chiang D, Jureen R, et al. · Diagn Microbiol Infect Dis · 2015Comparative Study, Evaluation Study
- Molecular test based on isothermal helicase-dependent amplification for detection of the Clostridium difficile toxin A gene.
Eckert C, Holscher E, Petit A, et al. · J Clin Microbiol · 2014Comparative Study, Evaluation Study
- Performance evaluation of the Aptima HSV-1 and 2 assay for the detection of HSV in cutaneous and mucocutaneous lesion specimens.
Sam SS, Caliendo AM, Ingersoll J, et al. · J Clin Virol · 2018Evaluation Study, Multicenter Study
- Detection of Group A Streptococcus in Pharyngeal Swab Specimens by Use of the AmpliVue GAS Isothermal Helicase-Dependent Amplification Assay.
Faron ML, Ledeboer NA, Granato P, et al. · J Clin Microbiol · 2015Evaluation Study, Multicenter Study
- Multicenter Evaluation of Meridian Bioscience HSV 1&2 Molecular Assay for Detection of Herpes Simplex Virus 1 and 2 from Clinical Cutaneous and Mucocutaneous Specimens.
Faron ML, Ledeboer NA, Patel A, et al. · J Clin Microbiol · 2016Evaluation Study
Other devices of this type
Also filed under product code OUY.
- Xpert TVCepheid · 510(k) 2016
- Aptima Trichomonas Vaginalis Assay - PantherGen-Probe, Inc. · De Novo 2013
- Aptima Trichomonas vaginalis AssayHologic, Inc. · 510(k) 2023
- BD MAX CTGCTV2, BD MAX SystemBecton, Dickinson and Company · 510(k) 2019
- Bd Max Ct/Gc/Tv, Bd Max InstrumentBecton, Dickinson and Company · 510(k) 2016
- Solana Trichomonas AssayQuidel Corporation · 510(k) 2016
- Bd Probetec Trichomonas Vaginalis (Tv) Qx Amplified Dna AssayBecton, Dickinson & CO · 510(k) 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.